Include Current Professional Labeling With Ad/Labeling Submissions

AI-verifiedblockerBinding lawCheckable — presence or a literal match settles it

Rule

Every submission of an advertisement or promotional labeling specimen to FDA under this section must include a copy of the product's current professional labeling.

Check

Confirm that a copy of the current professional labeling (e.g., the package insert) is included in the submission package alongside the promotional specimen. The test is whether the submission package contains a copy of the professional labeling that is current as of the submission, not merely the last approved version; absence of any copy, or inclusion of a superseded version, is a violation.

Where this comes from

21 CFR 314.81(b)(3)(i). The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

…the time of initial publication of the advertisement for a prescription drug product. Mailing pieces and labeling that are designed to contain samples of a drug product are required to be complete, except the sample of the drug product may be omitted. Each submission is required to be accompanied by a completed transmittal Form FDA-2253 (Transmittal of Advertisements and Promotional Labeling for Drugs for Human Use) and is required to include a copy of the product's current professional labeling. Form FDA-2253 is available on the Internet at http://www.fda.gov/opacom/morechoices/fdaforms/cder.html. (ii) Special reports. Upon written request the agency may require that the applicant submit the reports under this section at different times than those stated. (iii) Notification of a permanent discontinuance or an interruption in manufacturing. (a) An applicant of a prescription drug product must notif…

Open the original at these words on ecfr.gov ↗Read our full copy →

Document: 21 CFR 314.81
Version: 2026-09-16 — the link above is pinned to this date, so it shows the text as it stood then
Retrieved: 2026-09-21 from www.ecfr.gov
Fingerprint: f78a44bfc25afe4183ff9949…

Applies when

Naturepromotional

Launch stagepost-approval

How this rule was checked

Citation proven by script and passed an independent verifier running on a different model. Not yet confirmed by a human.

Drafted
claude-code:sonnet · 2026-09-21
Independent verification — revise
claude-code:opus · 2026-09-21
Reviewer's reasons
- The underlying obligation is supported: the source requires that each submission under (b)(3)(i) 'include a copy of the product's current professional labeling', and the rule is otherwise a faithful restatement.
- Overstated in one specific respect: the source says 'current professional labeling', but the rule statement says 'currently approved professional labeling' and the check says 'current approved professional labeling'. 'Current' and 'currently approved' are not interchangeable for drug labeling — labeling in current use can include changes made under a changes-being-effected supplement that FDA has not yet approved. As drafted, the rule would flag a submission that includes the labeling actually in current use, and would accept a superseded version that happens to be the last approved one. The word 'approved' is not in the source and should not be added.
- Atomic: one deliverable (a copy of the professional labeling) attached to the submission.
- 'deterministic' is correct once the wording is fixed: whether a copy of the professional labeling is in the submission package, and whether it is the current version, is settled by presence and by comparing versions.
- 'binding' is correct — regulation.
- The check's gloss of professional labeling as the package insert is acceptable, since § 314.81(b)(2)(iii)(b) in the same source text equates 'the package insert or professional labeling'; but it should be stated as an example rather than as a narrowing definition, since the submitted copy is of the professional labeling as such.
- applies_when (promotional, post-approval) is justified by the paragraph and by § 314.81(a); severity 'blocker' is defensible given § 314.81(d); locator 21 CFR 314.81(b)(3)(i) is correct.
Revised by the drafter
claude-code:sonnet · 2026-09-21
Independent verification — pass
claude-code:opus · 2026-09-21
Reviewer's reasons
- The quote is an operative clause of 21 CFR 314.81(b)(3)(i) — 'Each submission is required to be accompanied by a completed transmittal Form FDA-2253 ... and is required to include a copy of the product's current professional labeling.' The locator matches, and the language is mandatory ('is required to include'), so stating it as an obligation is not an overstatement.
- Atomic: the rule isolates the current-professional-labeling element and leaves the co-located Form FDA-2253 requirement and the timing requirement ('at the time of initial dissemination ... and at the time of initial publication') to other rules. That is the right cut; bundling them would have been the defect.
- The check's insistence that the labeling be current as of submission rather than any prior version follows from the word 'current' in the source and is not an added requirement.
- 'Deterministic' is correct: the check is whether a copy of the current professional labeling is present in the submission package. Presence/absence and a version comparison settle it; nothing turns on impression, adequacy, prominence or balance.
- applies_when is defensible: § 314.81(a) applies to applicants with approved applications and abbreviated applications, so the 'post-approval' launch-stage limit is drawn from the source, and the promotional limit matches (b)(3)(i)'s subject matter. No limit is invented, and the omission of a product-type restriction is appropriate since § 601.12(f)(4) extends this same submission regime to licensed biologics.
- Authority 'binding' is correct (codified FDA regulation) and 'blocker' is defensible for a mandatory element of a required FDA submission.
- Minor wording only, not grounds to withhold a pass: the Rule says 'under this section', which read literally is all of § 314.81; the surrounding language ('advertisement or promotional labeling specimen') makes clear it means § 314.81(b)(3)(i).

Nearby rules

US-ADM-002 US-ADM-003 US-ADM-004 US-ADM-005